Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• Telehealth Intervention By Pharmacists Collaboratively Enhances Hypertension Management & Outcomes
• New Dietary Guidelines Update Federal Nutrition Policy
• AbsoluteCare Launches Kidney Disease Care Initiative Across Ohio
• Dietary Guidelines For Americans, 2025-2030
• About 75% Of U.S. Adults Considered To Have Obesity Under New Lancet Commission Criteria
• Consumers With Chronic Conditions May Disproportionately Pay Out-Of-Pocket Costs For Preventive Care
• Passage Of Texas Proposition 14 Authorizes $3 Billion Investment To Fund The Dementia Prevention & Research Institute Of Texas
• Young Adults With Autism At Higher Risk Of Cardiometabolic Conditions
• Doctronic AI Begins Renewing Prescriptions For Those With Chronic Disease In Utah
• Novo Nordisk Launches U.S. Sales Of Pill Form Of Wegovy GLP-1 Medication For Weight Loss
• Best Practices To Integrate Your Systems Of Care: A Conversation With Srinivas Velamoor, President & CEO Of NextGen Healthcare
• CMS To Launch Voluntary Medicaid, Medicare Part D Program To Expand Access To Select GLP-1 Medications
• Weight Loss Programs Tailored To Veterans With SMI Could Reduce Obesity Rates Among This Population
• Depression & Anxiety Raise Risk Of Major Adverse Cardiac Events
• Prevalence Of Metabolic Syndrome Increased Slightly From 2013 To 2023, Averaging 38.7% For U.S. Adults

See All

Medicaid Coverage For Co-Occurring Chronic Pain & Opioid Addiction Varies Widely By State

Co-occurring chronic pain and opioid use disorder (OUD) are associated with a high disease burden for the patient, requiring comprehensive treatment approaches, yet Medicaid benefit structures for evidence-based therapies vary substantially across states, a recent study stated.  As the largest payer for substance use disorder (SUD) treatment and mental health services, Medicaid plays a crucial role in determining treatment access, the study stated. Recent policy reforms have expanded coverage for residential treatment and medications for… Read

• Chronic Disease Could Cost The United States $47 Trillion Over Next 15 Years
• FDA Seeks Statements Of Interest For TEMPO Digital Health Devices Pilot For Those With Chronic Disease
• Federal Government Awards $98 Million For Hepatitis C Elimination Initiative Pilot Services Contracts
• Medicare Chronic Care Management Model To Test Technology-Supported Care Plus Outcomes-Aligned Payments
• Almost 10% Of U.S. Adults Report Having Had Cancer

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.